|
|
 Previous Article | Table of Contents | Next Article 
Adenovirus-Mediated Transfer of Tissue-Type Plasminogen Activator Augments Thrombolysis in Tissue-Type Plasminogen Activator-Deficient and Plasminogen Activator Inhibitor-1-Overexpressing Mice
Peter Carmeliet,
Jean-Marie Stassen,
Ilse Van Vlaenderen,
Robert S. Meidell,
Désiré Collen, and
Robert D. Gerard
From the Center for Transgene Technology and Gene Therapy, Flanders Interuniversity Institute for Biotechnology, KU Leuven, Leuven, Belgium; and the Departments of Internal Medicine and Biochemistry, University of Texas Southwestern Medical Center, Dallas, TX.
Impaired fibrinolysis, resulting from increased plasminogen activator inhibitor-1 (PAI-1) or reduced tissue-type plasminogen activator (t-PA) plasma levels, may predispose the individual to subacute thrombosis in sepsis and inflammation. The objective of these studies was to show that adenovirus-mediated gene transfer could increase systemic plasma t-PA levels and thrombolytic capacity in animal model systems. Recombinant adenovirus vectors were constructed that express either human wild type or PAI-1-resistant t-PA from the cytomegalovirus (CMV) promoter. Both t-PA-deficient (t-PA-/-) and PAI-1-overexpressing transgenic mice were infected by intravenous injection of these viruses. Intravenous injection of recombinant adenovirus resulted in liver gene transfer, t-PA synthesis, and secretion into the plasma. Virus dose, human t-PA antigen, and activity concentrations in plasma and extent of lysis of a 125I-fibrin-labeled pulmonary embolism were all closely correlated. Plasma t-PA antigen and activity were increased approximately 1,000-fold above normal levels. Clot lysis was significantly increased in mice injected with a t-PA-expressing virus, but not in mice injected with saline or an irrelevant adenovirus. Comparable levels of enzyme activity and clot lysis were obtained with wild type and inhibitor-resistant t-PA viruses. Adenovirus-mediated t-PA gene transfer was found to augment clot lysis as early as 4 hours after infection, but expression levels subsided within 7 days. Adenovirus-mediated transfer of a t-PA gene can effectively increase plasma fibrinolytic activity and either restore (in t-PA-deficient mice) or augment (in PAI-1-overexpressing mice) the thrombolytic capacity in simple animal models of defective fibrinolysis.
Blood, Vol. 90 No. 4 (August 15), 1997:
pp. 1527-1534
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
S.K. Payeli, R. Latini, C. Gebhard, A. Patrignani, U. Wagner, T.F. Luscher, and F.C. Tanner
Prothrombotic Gene Expression Profile in Vascular Smooth Muscle Cells of Human Saphenous Vein, but Not Internal Mammary Artery
Arterioscler Thromb Vasc Biol,
April 1, 2008;
28(4):
705 - 710.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Renckens, J. J. T. H. Roelofs, S. Florquin, A. F. de Vos, J. M. Pater, H. R. Lijnen, P. Carmeliet, C. van 't Veer, and T. van der Poll
Endogenous Tissue-Type Plasminogen Activator Is Protective during Escherichia coli-Induced Abdominal Sepsis in Mice
J. Immunol.,
July 15, 2006;
177(2):
1189 - 1196.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-C. Murciano, S. Muro, L. Koniaris, M. Christofidou-Solomidou, D. W. Harshaw, S. M. Albelda, D. N. Granger, D. B. Cines, and V. R. Muzykantov
ICAM-directed vascular immunotargeting of antithrombotic agents to the endothelial luminal surface
Blood,
May 15, 2003;
101(10):
3977 - 3984.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. S. Zuckerbraun and E. Tzeng
Vascular Gene Therapy: A Reality of the 21st Century
Arch Surg,
July 1, 2002;
137(7):
854 - 861.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ai Kim, C. C. Hedrick, Dangci Xie, and M. J. Fisher
Adenoviral-Mediated Transfer of Tissue Plasminogen Activator Gene into Brain Capillary Endothelial Cells In Vitro
Angiology,
September 1, 2001;
52(9):
627 - 634.
[Abstract]
[PDF]
|
|
|
|
|
|
|
Bart De Geest, D. Stengel, M. Landeloos, M. Lox, L. Le Gat, D. Collen, P. Holvoet, and E. Ninio
Effect of Overexpression of Human Apo A-I in C57BL/6 and C57BL/6 Apo E-Deficient Mice on 2 Lipoprotein-Associated Enzymes, Platelet-Activating Factor Acetylhydrolase and Paraoxonase : Comparison of Adenovirus-Mediated Human Apo A-I Gene Transfer and Human Apo A-I Transgenesis
Arterioscler Thromb Vasc Biol,
October 1, 2000;
20
(10):
e68 - e75.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. Rosnoblet, U. M. Vischer, R. D. Gerard, J.-C. Irminger, P. A. Halban, and E. K. O. Kruithof
Storage of Tissue-Type Plasminogen Activator in Weibel-Palade Bodies of Human Endothelial Cells
Arterioscler Thromb Vasc Biol,
July 1, 1999;
19(7):
1796 - 1803.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Nagai, M. De Mol, H. R. Lijnen, P. Carmeliet, and D. Collen
Role of Plasminogen System Components in Focal Cerebral Ischemic Infarction : A Gene Targeting and Gene Transfer Study in Mice
Circulation,
May 11, 1999;
99(18):
2440 - 2444.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. J. Kullo, R. D. Simari, and R. S. Schwartz
Vascular Gene Transfer : From Bench to Bedside
Arterioscler Thromb Vasc Biol,
February 1, 1999;
19(2):
196 - 207.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Carmeliet, L. Moons, and D. Collen
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasis
Cardiovasc Res,
July 1, 1998;
39(1):
8 - 33.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
